
IRIDEX Investor Relations Material
Latest events

Q3 2024
IRIDEX
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from IRIDEX Corp
Access all reports
IRIDEX Corp is a medical technology company specializing in the development and commercialization of innovative laser-based systems for the treatment of eye diseases. The company’s products are primarily used in ophthalmology for the treatment of glaucoma, retinal diseases, and other vision-threatening conditions. IRIDEX’s laser systems and related consumables are designed to provide precise and minimally invasive treatment options for patients, improving outcomes and reducing recovery times. The company is headquartered in Mountain View, California, USA, and its shares are listed on the NASDAQ.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
IRIX
Country
🇺🇸 United States